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Abstract
Nearly 70% of breast cancer patients with advanced disease will develop bone metastases. Once established in bone, tumor
cells produce factors that cause changes in normal bone remodeling, such as parathyroid hormone-related protein (PTHrP).
While enhanced expression of PTHrP is known to stimulate osteoclasts to resorb bone, the environmental factors driving
tumor cells to express PTHrP in the early stages of development of metastatic bone disease are unknown. In this study, we
have shown that tumor cells known to metastasize to bone respond to 2D substrates with rigidities comparable to that of
the bone microenvironment by increasing expression and production of PTHrP. The cellular response is regulated by Rho-
dependent actomyosin contractility mediated by TGF-ß signaling. Inhibition of Rho-associated kinase (ROCK) using both
pharmacological and genetic approaches decreased PTHrP expression. Furthermore, cells expressing a dominant negative
form of the TGF-ß receptor did not respond to substrate rigidity, and inhibition of ROCK decreased PTHrP expression
induced by exogenous TGF-ß. These observations suggest a role for the differential rigidity of the mineralized bone
microenvironment in early stages of tumor-induced osteolysis, which is especially important in metastatic cancer since
many cancers (such as those of the breast and lung) preferentially metastasize to bone.
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Introduction
Nearly 70% of breast cancer patients with advanced disease will
develop bone metastases that are commonly associated with pain,
hypercalcemia, and pathologic fracture [1]. Once established in
bone, tumor cells begin to produce factors that cause changes in
normal bone remodeling. The best-described example is the
expression of parathyroid hormone-related protein (PTHrP),
which is expressed at higher levels in bone metastases from breast
cancers than it is in isolated primary tumors or soft tissue
metastases [2,3]. In the bone microenvironment, enhanced
expression of PTHrP stimulates osteoclasts to resorb bone [4].
As the bone is resorbed, the release of transforming growth factor
beta (TGF-ß) from the bone matrix contributes to further increase
PTHrP expression [5]. Thus, while TGF-ß released from the bone
matrix sustains the ‘‘vicious cycle’’ of bone resorption in the later
stages of bone disease, the environmental factors driving tumor
cells to express PTHrP in the early stages of development of
metastatic bone disease prior to bone resorption are unknown.
In addition to its osteolyic function in metastatic bone disease,
PTHrP also performs a number of normal physiological functions,
including the regulation of smooth muscle tone. Mechanically
transduced signals have been shown to regulate PTHrP expression
and secretion in a variety of smooth muscle beds [6]. Mechanical
distension of the abdominal aorta [7], the uterus, and the bladder
[8] in rats increased PTHrP expression by a factor of two or more.
Because of the dramatically (,10
6) higher rigidity of mineralized
bone tissue compared to breast tissue, tumor cells are likely to
generate higher cytoskeleton-dependent forces in the bone
microenvironment. Therefore, we hypothesized that the differen-
tial rigidity of the bone microenvironment might influence PTHrP
expression by tumor cells through mechanically transduced
signals.
Previous studies have shown that matrix rigidity regulates
invasiveness at the primary site [9,10]. When cells encounter a
mechanically rigid matrix, integrins become activated, which
stimulates RhoGTPase-dependent actomyosin contractility. How-
ever, while normal cells tune their contractility in response to
matrix rigidity, tumor cells exhibit altered tensional homeostasis,
as evidenced by their higher contractility and spreading relative to
non-malignant mammary epithelial cells on compliant matrices
[11]. Inhibition of RhoGTPase signaling in tumor cells by treating
with Rho-associated kinase (ROCK) inhibitors reduces tumor cell
contractility and spreading [11]. Additionally, ROCK expression
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metastatic tumors, and inhibition of ROCK signaling decreases
cell proliferation in vitro and metastasis to bone in vivo [12].
To test our hypothesis that cytoskeleton-dependent forces
regulate PTHrP expression in tumor cells, we designed a 2D
tumor cell mono-culture system. Previous studies investigating the
effects of matrix rigidity on cell migration, differentiation, and
invasion have utilized in vitro cell culture on 2D model substrates,
such as Matrigel
TM [13,14], crosslinked gelatin [15], and synthetic
hydrogels [16,17]. However, the applicability of these substrates to
the bone microenvironment is limited, due to the inability to
achieve a sufficiently high elastic modulus that is relevant to
mineralized bone tissue. In this study, we prepared polyacrylamide
(PAA) hydrogels as a model for breast tissue and poly(ester
urethane) films [18,19] as a model for tissues ranging from the
basement membrane to bone. We measured changes in gene
expression by metastatic tumor cells in response to the rigidity of
the substrate. In addition, we investigated the effects of ROCK
and TGF-ß inhibition and stimulation using pharmacological
agents and genetically modified cells to identify the signaling
pathways through which rigidity regulates gene expression.
Materials and Methods
Materials
Materials synthesis. Methyl 2,6-diisocyanatohexane (lysine
methyl ester diisocyanate, LDI) was purchased from Kyowa Hakko
USA (New York, NY). The structures of these polyisocyanates are
shown in Figure 1. Coscat 83, an organobismuth urethane catalyst,
was supplied by ChasChem, Inc. (Rutherford, NJ). Stannous
octoate, glycerol, poly(6-caprolactone) triol (300 Da), and 6-
caprolactone were purchased from Aldrich (St. Louis, MO), and
glycolide was purchased from Polysciences (Warrington, PA).
Glycerol was dried at 10 mm Hg for 3 hours at 80uCa n d
caprolactone was dried over anhydrous magnesium sulfate prior
to use. All other materials were used as received. Two-component
cast poly(ester urethane)s were mixed using a Hauschild
SpeedMixer
TM DAC 150 FVZ-K (FlackTek Inc., Landrum, SC).
Cell culture. Dulbecco’s modification of Eagle’s medium
(DMEM) and McCoy’s 5A were purchased from Invitrogen
(Carlsbad, CA). Fetal bovine serum (FBS) was purchased from
Hyclone Laboratories (Logan, UT). Penicillin, streptomycin, L-
glutamine, trypsin, sodium pyruvate, essential and non-essential
amino acids were all acquired from Mediatech (Manassas, VA).
MDA-MB-231, RWGT2 and MCF-7 cells were purchased from
ATCC (Manassas, VA). MDA-MB-231 and RWGT2 cells were
then selected for ability to metastasize to bone [20].
Antibodies, Primers and Reagents. The RNeasy
TM mini
kit was purchased from Qiagen (Valencia, CA). Superscript III
cDNA synthesis kits were purchased from Invitrogen (Carlsbad,
CA). qPCR primers for PTHrP, Gli2, TGF-ß and 18S (TaqMan)
were obtained from Applied Biosciences (Carlsbad, CA), while
primers for OPN, IL11, CXCR4, MMP9 and 18S (SYBR) were
purchased from Operon (Huntsville, AL) [21]. The PTHrP
immunoradiometric assay was purchased from Diagnostic
Systems Labs (Brea, CA). Antibodies for phospho-myosin light
chain 2 (Ser19, Ser19/Thr18) and anti-Rabbit IgG were procured
from Cell Signaling Technologies (Danvers, MA), while ß-actin and
Fibronectin antibodies came from Sigma (St. Louis, MO) and
Millipore (Billerica, MA), respectively. The ECL chemiluminescence
Figure 1. Schematic of materials synthesis and characterization. (A) Synthesis of PUR networks from an LDI quasi-prepolymer (red) and a
poly(e-caprolactone-co-glycolide) triol with molecular weight Mn=3w, where w is the equivalent weight (g eq
21). (B) Experimental values of the
elastic modulus E of PUR networks as a function of equivalent weight w. (C) Physical characteristics of polymer networks as calculated from rubber
elasticity theory. Em and Gm represents measured elastic and shear moduli, n2 is the fraction of polymer in the swollen mass, Mc is the calculated
molecular weight between cross-links and Ec and Gc are the calculated elastic and shear moduli. (D) Schemes for providing a uniform surface
concentration of fibronectin (Fn) for polyurethane networks and polyacrylamide gels.
doi:10.1371/journal.pone.0015451.g001
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substrate kit was produced by Vector Laboratories (Burlingame,
CA). The mechanotransduction inhibitors Blebbistatin and Y27632
were both procured from Sigma (St. Louis, MO).
Methods
Synthesis of substrates for in vitro studies. Polyurethane
(PUR)filmsandpolyacrylamide(PAA)hydrogelsweresynthesizedto
provide 2D substrates with elastic moduli ranging from ,1kPa to
.1 GPa for in vitro studies of mechanosensitivity. PUR substrates
were synthesized by reactive liquid molding of a lysine methyl ester
diisocyanate (LDI) quasi-prepolymer, a poly(6-caprolactone-co-
glycolide) triol, and COSCAT 83 bismuth catalyst using published
techniques.[18] Briefly, the quasi-prepolymer was synthesized by
charging poly(6-caprolactone) triol (PCL, 300 g mol
21) to a flask
fitted with a reflux condenser and heated to 60uC in an oil bath.
Lysine diisocyanate methyl ester (LDI, Kyowa Hakko) was then
charged, the reactor immersed in an oil bath maintained at 90uC,
and Coscat 83 was added while stirring under dry argon. The
reaction was allowed to proceed for three hours under vacuum at
90uC, at which time the reactor was purged with dry argon and the
quasi-prepolymer was poured into a vessel stored at 4uC. Structure
was verified by nuclear magnetic resonance spectroscopy (NMR,
Bruker, 300 MHz), molecular weight was measured byGPC, and %
free NCO was measured by titration.
Polyester triols ranging from 300 to 3000 g mol
21 (100–1000 g
eq
21) were synthesized from a glycerol starter, 70% caprolactone
and 30% glycolide monomers, and stannous octoate catalyst as
described previously [22]. Briefly, the appropriate amounts of
dried glycerol, dried 6-caprolactone, glycolide, and stannous
octoate (0.1 wt-%) were mixed in a 100-ml flask and heated
under an argon atmosphere with mechanical stirring to 135uC.
The mixture was allowed to react for ,30 h and subsequently
removed from the oil bath. NMR was used to verify the structure
of the polyester triols, with deuterated dichloromethane (DCM) as
a solvent. The hydroxyl (OH) number was measured by titration
(Metrohm 798 MPT Titrino) according to ASTM D-4662-93 as
described [18]. Substrates were synthesized by mixing an
appropriate amount of poly(6-caprolactone-co-glycolide) triol with
LDI quasi-prepolymer, and COSCAT 83 catalyst (Vertellus) for
20s in a Hauschild SpeedMixer
TM DAC 150 FVZ-K vortex mixer
(FlackTek, Inc, Landrum, SC). The targeted index (ratio of NCO
to OH equivalents times 100) was 105. The resultant mixture was
poured into the wells of a tissue culture plate and allowed to cure
for 24h at 60uC. To facilitate cell adhesion and ensure that the
surface chemistry was constant for all substrates tested, fibronectin
(Fn) was adsorbed to the surface of the substrates by incubating
them in a 4 mg/mL solution of Fn in PBS at 4uC overnight.
Polyacrylamide (PAA) hydrogels were synthesized by copoly-
merizing a 10% solution of acrylamide and bis-acrylamide in
water via free-radical polymerization using a redox pair of
initiators (tetramethyl ethylene diamine (TEMED) and 10%
ammonium persulphate (APS) in water). Additionally, acrylic acid
N-hydrosuccinimide (NHS) ester was copolymerized to the surface
of the gels. The NHS-acrylate layer was then allowed to react with
a solution of Fn in HEPES. To measure the surface concentration
of Fn, coated substrates were incubated in a solution of Fn
antibody (1:1000) followed by incubation with a secondary HRP-
conjugated antibody. The relative amount of adsorbed antibody
was then quantified by reaction with 29-azino-bis(3-ethylbenzthia-
zoline-6-sulphonic acid) (ABTS) and subsequent optical density
reading at 405nm. All PUR and PAA substrates were prepared at
the same surface concentration of Fn that yielded an optical
density of 0.12 absorbance units cm
22.
Dynamic mechanical properties of substrates. Tensile
modulus and strength of the PUR films were measured at 37uC for
361561mm films using a TA Instruments Q800 DMA (controlled
force displacement ramp, 1 N min
21 to 18 N min
21) [22].
Storage and loss moduli for the polyacrylamide gels under shear
conditions were measured using a TA Instruments AR-G2
Rheometer (TA Instruments, New Castle, DE) at 37uC, using a
20-mm circular head as described previously [15,23]. Gels were
compressed between a heated Peltier plate and a 20-mm upper
plate and subjected to an oscillating (0.1–10 Hz) shear strain that
was validated to be in the linear range by strain sweep tests.
Swelling experiments and calculation of network mesh
size. To determine the mesh size of the polymer network, PUR
substrates were swollen in dichloromethane for 24h at room
temperature, while PAA gels were swollen in water and
subsequently lyophilized to determine swelling ratios. The
molecular weight between crosslinks, Mc, was then determined
from the Flory-Rehner equation [24],
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where n2 is the volume fraction of the polymer in the swollen mass,
x1 is the Flory-Huggins interaction parameter, V1 is the molar
volume of the solvent, and n represents the number of active
network chain segments per unit volume. The molecular weight
between crosslinks is then given by
Mc~
r
n
ð2Þ
where r is the density of the polymer network and n is the crosslink
density (mol cm
23). Mesh size, xi, was then estimated by [25]
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where Mr is the molecular weight of the repeat unit and l is the
carbon-carbon bond length. Assuming the materials were perfectly
elastic (Poisson’s ratio=0.5), the elastic and shear moduli (E, G)
are related to the crosslink density:
E~3nRT ð4Þ
E~3G ð5Þ
Cell culture. MDA-MB-231 and RWGT2 cells were
maintained and cultured at 37uC under 5% CO2 in 16DMEM
plus 10% heat inactivated FBS and 1% penicillin/streptomycin.
MCF7 cells were maintained and cultured at 37uC under 5% CO2
in 16 McCoy’s 5A plus 10% heat inactivated FBS, and 1%
penicillin/streptomycinm L-glutamine, amino acids, non-essential
amino acids and sodium pyruvate each. Cells were harvested with
trypsin from substrates after 24h in culture for mRNA extraction
(Qiagen RNeasy kit). Conditioned media was collected after 48h in
the presence of protease inhibitor for secreted protein analysis. To
image cell morphology as a function of substrate rigidity, cells
stably expressing GFP were cultured on 0.45kPa (D), 3.3MPa (E)
and 1.7GPa (F) substrates and visualized at 24 hours using phase
contrast, GFP and DAPI.
Quantitative real-time PCR. To measure changes in gene
expression, mRNA reverse transcription was carried out using the
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was extracted using the RNeasy Mini Kit. The SuperScript III First
Strand Synthesis System for quantitative RT-PCR primed with
random hexamers was used to synthesize cDNA using between 1 and
5 mg total RNA. The expression of PTHrP, Gli2, and TGF-ß was
measured by quantitative RT-PCR using validated TaqMan primers
with the 7300 Real-Time PCR System (Applied Biosciences). Assays
were performed in triplicate on the RealPlex Machine (Eppendorf)
under the following cycling conditions: 95uC for 15 seconds, 58uCfo r
30 seconds, and 68uC for 30 seconds. Quantification was performed
using the absolute quantitative for human cells method using 18S as
an internal control. The expression of osteopontin (OPN), interleukin
11 (IL-11), CXCR4, connective tissue growth factor (CTGF), and
matrix metalloproteinase- 9 (MMP-9) were determined using SYBR
green primers as described previously [21].
Immunoradiometric assays. PTHrP protein secretion was
measured in conditioned medium using a two-site immunora-
diometric assay (IRMA) per manufacturer’s instructions. All secreted
protein values were normalized for cell number.
TGF-ß signaling assay. MDA-MB-231 cells were transiently
transfected with 1 mg 3TPLux, a TGF-ß responsive reporter
construct [26], using lipofectamine plus (Invitrogen). pRLTK
Renilla was cotransfected as a control reporter vector. After 24h in
serum-free culture on substrates ranging from 1.7GPa to 0.45kPa,
cells were lysed in Passive Lysis Buffer (Promega) and the oxidation of
luciferin was measured using a luminometer (TD 20/20, Turner
Designs) using a Dual Luciferase Assay Kit (Promega) per
manufacturer’s instructions. Luciferase activity was then normalized
by the Renilla control.
Western Blotting. Cells cultured as described above were
harvested into a radio-immunoprecipitation assay lysis buffer
containing a cocktail of protease inhibitors (Roche, Basel,
Switzerland). Equal protein concentrations were prepared for
loading with NuPAGE sample buffer (Invitrogen) and separated
on a gradient (4%–20%) SDS-PAGE gel (Biorad). After transferring
to a PVDF, membranes were blocked with 5% BSA in TBS
containing0.1%Tween-20for1hatroomtemperature,followedby
incubation with either phospho-myosin light chain 2 (Ser19) or
phospho-myosin light chain 2 (Thr18/Ser19) (1:1000) antibodies
overnight at 4uC. After washing,membranes wereblotted withanti-
rabbit IgG (1:5000), and bands were detected by enhanced
chemiluminescence. Membranes were then stripped and reprobed
using an antibody for ß-actin (1:5000) as a loading control.
Inhibition of mechanotransduction. Cells were plated as
described above and allowed to adhere for 4h, at which point they
were treated with either Y27632 (20mM) or Blebbistatin (50mM).
Cells were harvested 24h or 48h post-treatment for mRNA and
secreted protein and analyzed as described above. MDA-MB-231,
RWGT2 and MCF-7 cells were transfected with either cDNA
encoding a dominant active (D4) or dominant negative (KDD4)
mutant of ROCK [27,28] (a generous gift of Dr. Kazuyuki Itoh,
Osaka Medical Center for Cancer and Cardiovascular Diseases,
Osaka, Japan) using lipofectamine plus (Invitrogen) per
manufacturer’s instructions.
Inhibition of ROCK in the presence of exogenous TGF-
ß. Cells were plated and treated with either Y27632 or
Blebbistatin as described previously. Cells were then either co-
treated with 5 ng/mL TGF-ß or TGF-ß vehicle (5% BSA-HCl)
and harvested for mRNA after 24h for qPCR analysis.
Results
Characterization of PUR and PAA substrates. The
characterization of the substrates is summarized in Figure 1. As
shown in Figure 1A and B, the PUR films were crosslinked
networks. The elastic modulus of the films increased with
decreasing equivalent weight, defined as the molecular weight
divided by the functionality (f=3 for a triol). The mesh size of the
PUR films ranged from 8.7–24 nm, which is at least 2 orders of
magnitude smaller than the size of the cells. Therefore, the cells
migrate on the surface since they cannot penetrate the films. The
mesh size of the PAA gels was 3.3 mm, which is also smaller than
the size of the cells. As shown in Figure 1C, we obtained
reasonable agreement (within a factor of 2) between the measured
modulus and that calculated from the swelling experiments using
eq (4). PUR substrates were coated with Fn by adsorption, while
Fn was grafted to PAA gels (Figure 1D). The concentration of Fn
on all surfaces was maintained at 0.12 absorbance units cm
22 by
controlling the concentration of Fn in the solution.
Bone-like mechanical properties stimulate expression of
PTHrP. To investigate the effects of substrate modulus on gene
expression of cancer cells in vitro, we synthesized 2D substrates with
tunable elastic moduli ranging from 0.45 kPa to 67 GPa for
culture with several cell lines, namely MDA-MB-231 (osteolytic
metastatic mammary adenocarcinoma), RWGT2 (osteolytic
metastatic lung squamous cell carcinoma), and MCF-7 (non-
osteolytic ductal mammary carcinoma). MDA-MB-231 and
RWGT2 cells showed 2.5-fold and 2-fold increases in PTHrP
mRNA expression respectively in response to substrates with
moduli exceeding 1 GPa compared to substrates with moduli
,100 kPa (Figure 2A and B). In contrast, MCF-7 cells, which are
known not to cause osteolytic lesions showed no difference in
PTHrP expression in response to substrate stiffness (Figure 2C).
The effects of substrate modulus on PTHrP gene expression
followed a sigmoid curve that saturates between 1.7 and 67GPa,
which overlaps with the elastic modulus of bone. PTHrP secretion
data measured by IRMA changed similarly for all cell lines
(Figure 2A–C). Additionally, the morphology of MDA-MB-231
cells changed with substrate rigidity (Figure 2D–F), where GFP
(green) is expressed throughout the cell and the DAPI (blue) stain
binds to the DNA in the nucleus. Similar effects were observed
with RWGT2 cells, and no effects were obtained with MCF7 cells
(data not shown).
Expression of Gli2, a transcription factor known to regulate
PTHrP [4], also showed a 5-fold increase on hard substrates in
both MDA-MB-231 and RWGT2 (Figure 3) but not in MCF-7
cells (data not shown). To verify that these data were not the result
of an overall down-regulation of gene expression on soft substrates,
several other factors of known importance in bone metastases [29]
were examined as summarized in Table 1. Expression of the
osteolytic factor IL-11 was relatively insensitive to substrate rigidity
for all three cell lines tested. Factors showing the most dramatic
change in expression as a function of rigidity include osteopontin
(OPN) and MMP-9. Expression of OPN, which is incidentally
associated with primary site invasion, was 5–18 times higher when
MDA-MB-231 or RWGT2 cells were seeded on soft substrates.
Interestingly, expression of OPN by MCF-7 cells was relatively
independent of rigidity. Expression of MMP-9 was 10–30 times
higher on soft substrates for MDA-MB-231, but the effects of
rigidity on MMP-9 expression observed for RWGT2 and MCF-7
cells were substantially smaller.
Substrate-mediated gene expression changes in bone-
metastatic cancers are regulated by ROCK-I. ROCK
signaling regulates actomyosin contractility and cytoskeleton-
dependent forces by phosphorylating motor proteins, such as the
regulatory MLC, LIMK1/2 and MYPT1 (myosin-binding subunit
of MLC) [12]. Thus, ROCK activation leads to increased
actomyosin contractility, which led us to question whether the
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ROCK. To determine whether the observed changes in
mechanotransduction were linked to expression of
osteoclastogenic factors, we first cultured MDA-MB-231 cells on
soft (3.3 MPa) and hard (1700 MPa) PUR substrates and
measured ROCK activity after 24h by Western blotting. As
shown in Figure 4A, cells seeded on more rigid substrates
expressed higher levels of phosphorylated MLC (pMLC),
implying that ROCK activity increased on more rigid substrates.
To further test the hypothesis that modulus effects on PTHrP
expression were mediated by ROCK, we pharmacologically
inhibited mechanotransduction in MDA-MB-231 and RWGT2
cells on 2 GPa tissue culture polystyrene substrates with
blebbistatin or the ROCK inhibitor, Y27632. Inhibition of
actomyosin contractility by blebbistatin and inhibition of
ROCK-I by Y-27632 induced a significant decrease in PTHrP
Figure 2. Expression and secretion of PTHrP by osteolytic, metastatic tumor cells increases with increasing substrate modulus.
PTHrP mRNA normalized by 18S as measured by qPCR and secreted PTHrP as measured by IRMA for (A) MDA-MB-231 , (B) RWGT2, and (C) MCF-7 cells
on substrates of increasing elastic modulus. *,#=p,0.05; **,##=p,0.01; ***,###=p,0.005 compared to 0.00045MPa value. Changes in MCF-7
cells were not significant. (D)–(F) Morphology of MDA-MB-231 cells cultured on substrates of varying elastic modulus 4 hours post-attachment. Nuclei
were stained using DAPI (blue) and cells were visualized with both visible light and GFP (green). Similar effects of the modulus on cell morphology
were observed for RWGT2 cells, while no effects were observed for MCF-7 cells.
doi:10.1371/journal.pone.0015451.g002
Figure 3. Expression of Gli2 and by MDA-MB-231 and RWGT2 cells increases with increasing substrate modulus. Expression of Gli2
mRNA normalized by 18S as measured by qPCR for (A) MDA-MB-231 and (B) RWGT2 cells on substrates of varying elastic modulus. Gli2 signaling
increased 25-fold as the modulus increased from 3.3 to 1700 MPa (data not shown). *,#=p,0.05; **,##=p,0.01; ***,###=p,0.005 compared to
0.00045MPa value.
doi:10.1371/journal.pone.0015451.g003
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(Figure 4B), suggesting that the upregulation of PTHrP on rigid
substrates is mediated by ROCK. Conversely, pharmacologically
inhibiting mechanotransduction with either blebbistatin or
Y27632 resulted in an increase of OPN mRNA expression in
both MDA231 and RWGT2 (data not shown). Neither
blebbistatin nor Y27632 had an effect on IL-11 mRNA
expression in either cell type (data not shown). MDA-MB-231
cells were also genetically modified to produce constitutively active
(MDA-D4) and dominant negative (MDA-KDD4) forms of
ROCK. As shown in Figure 4C, expression of PTHrP by MDA-
D4 cells seeded on 2 GPa substrates was upregulated relative to
plasmid control (pc) cells and did not increase with increasing
modulus. Expression of PTHrP by MDA-KDD4 cells seeded on
the same substrates was down-regulated and did not increase with
increasing substrate rigidity. Taken together, the data in Figure 4
Table 1. Expression of a selected panel of genes associated
with osteolytic bone disease as a function of substrate rigidity.
MDA-MB-231 RWGT2 MCF-7
Gene 3.3 MPa 1700 MPa 3.3 MPa 1700 MPa 3.3 MPa 1700 MPa
IL-11 1.5 1.4 1.1 1.1 1.1 21.1
OPN 218 218 25.0 22.3 1.4 21.1
MMP-9 232 211 21.3 21.4 3.7 1.3
CXCR4 22.0 1.1 1.4 1.7 2.4 1.3
CTGF 1.8 2.0 1.1 1.0 2.4 1.3
Values are listed as fold increase in gene expression compared to that
measured for the PAA hydrogel.
doi:10.1371/journal.pone.0015451.t001
Figure 4. Mechanotransduction signals are regulated by values of the substrate modulus in the MPa range. (A) Western blot analysis of
myosin light chain phosphorylation shows higher pMLC expression by MDA-MB-231 cells seeded on more rigid (1700 MPa) relative to softer
(3.3 MPa) PUR substrates. (B) Pharmacological inhibition of actomyosin contractility (blebbistatin) and ROCK (Y-27632) decreases PTHrP gene
expression and protein secretion in MDA-MB-231 cells. Similar patterns were observed for RWGT2 cells (data not shown). The optimal doses of
blebbistatin and Y-27632 were identified to be 50 uM and 20 uM, respectively through dose-response experiments (data not shown). (C) PTHrP is
over-expressed and does not increase with rigidity in MDA-MB-231 cells genetically modified to express a constitutively active form of ROCK (MDA-D4
cells). Similarly, PTHrP expression does not increase with rigidity in MDA-MB-231 cells genetically modified to express a dominant negative form of
ROCK (MDA-KDD4 cells). MDA cells transfected with a plasmid control (MDA-pc) show significant increases in PTHrP expression with rigidity.
*,#=p,0.05; **,##=p,0.01; ***,###=p,0.005.
doi:10.1371/journal.pone.0015451.g004
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expression are mediated by ROCK.
TGF-b mediates the effects of substrate rigidity on Gli2
and PTHrP expression through ROCK. While Figure 4
shows that ROCK regulates PTHrP expression, TGF-ß is also
known to stimulate PTHrP production [5]. Therefore, we
investigated its role in regulating the response of the tumor cells
to rigidity. As shown in Figure 5A, MDA-MB-231 cells transfected
to express a dominant negative form of the TGF-ß Type II
receptor (MDA-TbRIIDcyt cells) showed only a #1.6-fold
increase in PTHrP expression as substrate rigidity increased
from 0.45 kPa to 1700 MPa. Similarly, MCF-7 cells, which do not
express the TGF-ß Type II receptor, also showed #1.1-fold
increase in PTHrP gene expression with substrate rigidity
(Figure 5A). Thus, cells that are non-responsive to TGF-ß did
not respond to substrate modulus. Interestingly, intracellular TGF-
ß signaling, as measured by the 3TPLux assay, increased with
substrate rigidity, as shown in Figure 5B. This is at least in part due
to an increase in TGF-ß1 expression by cells on more rigid
substrates (Figure 5C).
We next investigated whether blocking ROCK inhibits the
effects of exogenous TGF-ß on the stimulation of Gli2 and PTHrP
expression by treating cells with TGF-ß and inhibiting mechan-
otransduction with blebbistatin (Figure 6A and B) or Y27632
(Figure 6C and D). We found that blebbistatin blocked the ability
of TGF-ß to stimulate Gli2 and PTHrP expression. Similar results
were seen with Y27632 treatments. Using a molecular approach,
we treated the KDD4 cells with TGF-ß and found that TGF-ß
could no longer stimulate Gli2 (Figure 6E) or PTHrP (Figure 6F),
thus suggesting that ROCK is required for TGF-ß to stimulate
Gli2 and PTHrP.
Discussion
How tumor cells respond to matrix rigidity is an area of
increasing interest, with several groups investigating how the
increasing rigidity of soft tissue can alter tumor cell behavior and
gene expression. Mechanically transduced signals can induce
phenotypic transformation of cells by altering Rho-dependent
actomyosin contractility to regulate cellular outcomes, including
motility and invasiveness [30], tissue morphogenesis [31],
invadopodia activity [32], and stem cell differentiation [33]. While
the invasiveness of cancer cells has been reported to increase with
the rigidity of the matrix for soft hydrogels [9,10,15,23], the range
of substrate rigidity used to investigate cellular responses was
generally ,100 kPa. A recent study has shown that single cell
populations (SCPs) derived from MDA-MB-231 cells exhibited
increased proliferation and migration when seeded on matrices
with rigidities corresponding to the native rigidities of the organs
where metastasis was observed [30]. Thus SCPs targeted
specifically to bone proliferated faster and were more invasive
on rigid tissue culture polystyrene compared to soft PAA gels.
However, whether the differential rigidity of bone alters expression
of osteolytic factors by tumor cells has not been investigated. In
this study, we show that not only do cells respond with changed
behavior when exposed to substrates with rigidities comparable to
bone, but also that specific genes involved in tumor-induced bone
disease are upregulated. This is especially important in metastatic
cancer, since many cancers (such as those of the breast and lung)
preferentially metastasize to bone.
Expression of the osteolytic factor PTHrP is more prevalent in
bone versus soft tissue metastases as observed in clinical
populations [2,3]. We hypothesized that the differential rigidity
of the bone microenvironment induces tumor cells to increase
expression of osteolytic factors by altering Rho-dependent
actomyosin contractility. To test our hypothesis, we cultured
tumor cells on 2D substrates with rigidities ranging from that of
breast tissue to mineralized bone. Considering that tumor cell
interactions with Fn are important for the development of
secondary tumors inside the bone marrow stroma [34], substrates
were uniformly coated with Fn to better simulate the bone
microenvironment and control the surface chemistry. When
MDA-MB-231 or RWGT2 tumor cells were grown on rigid
substrates (1.7 and 67 GPa) with moduli bracketing that of
mineralized bone matrix (18.4 GPa) [35], both Gli2 and PTHrP
expression were 2–4 times higher compared to soft PAA gels
(0.45 kPa). Gli2 and PTHrP expression did not increase for
moduli above 1 GPa. When cells were seeded on a soft PUR
substrate with modulus (3.3 MPa) approaching that of the
basement membrane [36], PTHrP expression was intermediate
between the soft PAA and the rigid PUR substrates. Similar
observations have been reported for MC3T3-E1 pre-osteoblastic
cells, which showed higher expression of markers of osteoblast
differentiation when cultured on rigid TCPS (2 GPa) compared
Figure 5. TGF-ß mediates the response of MDA-MB-231 cells to substrate rigidity. (A) PTHrP gene expression increases significantly for
MDA-MB-231 cells transfected with the plasmid control (MDA-pc), while MDA-MB-231 cells transfected to express a dominant negative form of the
TGF-ß Type II receptor (MDA-TbRIIDcyt ) and MCF-7 cells that do not express the TGF-ß Type II receptor show no increase in expression with rigidity.
(B) TGF-ß signaling was measured in MDA-MB-231 cells transfected with the 3TP-Lux TGF-ß reporter construct. This showed an increase in TGF-ß
signaling when cells are grown on rigid substrates. (C) TGF-ß1 mRNA expression by MDA-MB-231 cells increased on more rigid substrates.
*,#=p,0.05; **,##=p,0.01; ***,###=p,0.005 compared to 0.00045MPa value.
doi:10.1371/journal.pone.0015451.g005
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that actomyosin appeared diffuse for cells cultured on soft gels, in
contrast to the stress fibers and strong focal adhesions that
predominate when cells were cultured on rigid (e.g., 30–100 kPa)
gels or glass (67 GPa) [37]. Based on these observations, it has
been suggested that cells cultured on substrates having a modulus
equal to or greater than that of stiff gels are in a state of isometric
contraction. However, our data show that tumor cells respond to
substrate rigidity in the MPa range. While other genes may also
increase in addition to Gli2 and PTHrP, we found minimal
changes in many of the genes identified previously to be
associated with metastasis to bone [29]. Two genes that did
change were OPN and MMP-9, which were expressed at a
greater amount on softer substrates. This is consistent with
clinical data correlating high expression of OPN in metastatic
tumor cells [38].
Figure 6. Inhibition of mechanotransduction and ROCK suppresses PTHrP expression induced by exogenous TGF-ß. Treatment with
blebbistatin inhibits expression of (A) Gli2 and (B) PTHrP by MDA-MB-231 cells cultured on TCPS. Treatment with 5 ng/ml exogenous TGF-ß increases
PTHrP and Gli2 expression, and treatment with both TGF-ß and blebbistatin reduces expression to levels observed for blebbistatin alone. Similarly,
treatment of MDA-MB-231 cells with the ROCK inhibitor Y-27632 inhibits (C) Gli2 and (D) PTHrP expression. In the presence of both exogenous TGF-ß
and Y-27632, both PTHrP and Gli2 expression are significantly reduced, but PTHrP expression is only partially inhibited relative to treatment with Y-
27632 alone. Expression of (E) Gli2 and (F) PTHrP in MDA-MB-231 cells genetically modified to express a dominant negative form of ROCK (MDA-MB-
231 KDD4) is significantly lower than that measured for plasmid control MDA-MB-231 cells. Treatment with exogenous TGF-ß does not significantly
increase Gli2 or PTHrP expression in KDD4 cells. *,#=p,0.05; **,##=p,0.01; ***,###=p,0.005.
doi:10.1371/journal.pone.0015451.g006
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hypercalcemia of malignancy (HHM), PTHrP is also expressed by
a variety of normal fetal and adult cells, including keratinocytes,
mammary epithelial cells, renal tubular epithelial cells, chondro-
cytes, osteoblasts, and smooth muscle cells [6]. Mechanical stretch
induces PTHrP gene expression and protein production in a
variety of smooth muscle beds [6], including the abdominal aorta
[7], uterus [39,40], and bladder [8]. In addition, mechanical
distension of breast tissue caused by suckling induces a rapid and
transient response in PTHrP mRNA expression and protein
concentration in lactating mammary tissue in rats [41]. While
mechanically induced PTHrP signaling has been shown for
normal cells, these effects have not been previously reported for
metastatic tumor cells.
When cells encounter a mechanically rigid matrix, integrins
become activated, which stimulates RhoGTPas-dependent acto-
myosin contractility [11]. Thus cells exert actomyosin contractility
and cytoskeleton-dependent forces in response to matrix rigidity
cues. Inhibition of RhoGTPase signaling in tumor cells by treating
with ROCK or myosin 2 inhibitors reduces tumor cell contractility
and spreading [11], as well as invadopodia-associated extracellular
matrix degradation [15]. Similarly, in this study we observed that
expression of phosphorylated myosin light chain (pMLC), which is
regulated by ROCK, is increased on rigid substrates. Further-
more, inhibition of tumor cell actomyosin contractility in both
pharmacological and genetic models decreased Gli2 and PTHrP
expression. A recent study has suggested that increased ROCK
signaling contributes to breast cancer metastasis [12]. ROCK
expression is increased in metastatic human mammary tumors and
breast cancer cell lines, and inhibition of ROCK signaling reduces
tumor cell metastasis to bone in vivo. Taken together, these
observations suggest that inhibiting ROCK or the pathway it
stimulates may be an effective approach for treatment of breast
cancer metastases in the clinic. Since ROCK is ubiquitously
expressed in many tissues and is required for normal mechan-
otransduction responses in cells, global inhibition in patients may
not be an ideal clinical approach. However, the ROCK inhibitors
fasudil and Y-27632 have been used successfully in preclinical
models of pulmonary and cardiac disease, and a few clinical
studies have shown that fasudil is a safe and effective treatment for
patients with severe pulmonary hypertension [42].
Mechanical signals induced by substrate rigidity regulate the
expression of Gli2 and PTHrP though ROCK. Our observation
that the expression of Gli2 by tumor cells is regulated by matrix
rigidity is consistent with previous studies suggesting that Hh genes
are regulated during development by mechanically transduced
signals [43,44]. While ROCK is ubiquitously expressed in many
tissues and cells in the body, the postnatal expression of Gli2 is
primarily restricted to the growth plate [45] and hair follicle
[46,47]. Thus Gli2 may be a potentially more useful target than
ROCK for treating bone metastases in the clinic. Preclinical
studies have indicated that inhibiting Gli2 activity reduces PTHrP
expression and osteolysis [48].
Interestingly, substrate rigidity activates ROCK through a
TGF-ß-dependent mechanism. As shown in Figure 6, blocking
ROCK either pharmacologically or genetically inhibits most of the
incremental PTHrP expression resulting from treatment with
exogenous TGF-ß. In addition, TGF-ß signaling increases with
substrate rigidity, which has also been reported for myofibroblasts
cultured on relatively rigid (.10 kPa) hydrogels, where cell-
generated forces deform the TGF-ß latent complex resulting in
release of soluble TGF-ß [49,50]. However, in the present study,
the expression of TGF-ß1 (but not ß2 or ß3) also increased with
rigidity, suggesting a pivotal role for autocrine TGF-ß signaling in
this response. This observation is in agreement with previous
studies reporting that mechanical stretch or laminar shear stress
increases TGF-ß expression and production in endothelial [51,52]
and activated hepatic stellate (HSCs) cells [53]. A mechanotrans-
duction pathway requiring autocrine TGF-ß signaling was found
to regulate expression of perlecan in endothelial cells [51]. In
another study, transfection of HSCs with a dominant negative
form of Rho inhibited the increased production of TGF-ß induced
by mechanical stretch [53]. In the bone microenvironment, as
osteoclasts resorb host bone, TGF-ß released from the bone matrix
stimulates the tumor cells to produce more PTHrP, leading to the
vicious cycle of osteoclast-mediated bone resorption associated
with metastatic bone disease [5]. Our data show that the increased
PTHrP expression induced by exogenous TGF-ß in vitro is
mediated by the rigidity of the substrate on which the tumor cells
are cultured. These observations suggest a role for the differential
rigidity of the mineralized bone microenvironment in both the
initiation and maintenance of the vicious cycle when osteolytic
tumor cells metastasize to bone.
While the interpretation of these experiments is somewhat
limited by the use of 2D surfaces, which are known to regulate
migration and invasion of tumor cells in ways that differ from 3D
matrices [14], the 2D substrates enabled us to independently
investigate how rigidity influences gene expression over the
0.45 kPa to 67 GPa range. A recent study has shown that MDA-
MB-231 single cell clonal populations proliferated faster on 2D
substrates having mechanical properties comparable to that of the
organs where metastasis was observed [30]. Thus the response to
rigidity in various SCPs in 2D cell culture correlated with the
tissue tropism observed in vivo. In the present study, tumor cells
changed their gene expression patterns when encountering
substrates having rigidities in the MPa to GPa range, suggesting
that the differential rigidity of the bone microenvironment may
contribute to the initial establishment and function of tumor cells
in bone. Although the modulus of the tissue that the cells are
interacting with in the bone microenvironment is not precisely
known, mineralized bone tissue is orders of magnitude more rigid
than the primary site [54], and well within the range of the rigid
substrates used in this study. We are currently developing a 3D
co-culture system in vivo to capture more representative features of
the bone microenvironment, such as cellular migration and
invasion in a 3D matrix and tumor-stromal cell interactions.
In this study, we have shown that tumor cells respond to 2D
substrates with rigidities comparable to that of bone by increasing
expression and secretion of the osteolytic factor PTHrP. The
cellular response is regulated by Rho-dependent actomyosin
contractility mediated by TGF-ß signaling. Inhibition of ROCK
using both pharmacological and genetic models decreased
PTHrP expression. Furthermore, cells expressing a dominant
negative form of the TGF-ß receptor did not respond to substrate
rigidity, and inhibition of ROCK decreased PTHrP expression
induced by exogenous TGF-ß. These observations suggest a role
for the differential rigidity of the mineralized bone microenvi-
ronment in early stages of tumor-induced osteolysis, which is
especially important in metastatic cancer since many cancers
(such as those of the breast and lung) preferentially metastasize to
bone.
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